Measuring disease-specific quality of life in clinical trials.
about
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trialsHealth related quality of life in Parkinson's disease: a systematic review of disease specific instrumentsUnmet health needs in patients with coronary heart disease: implications and potential for improvement in caring servicesShort forms of the Child Perceptions Questionnaire for 11-14-year-old children (CPQ11-14): development and initial evaluation.Development of a Health-Related Quality of Life Questionnaire (HRQL) for patients with Extremity Soft Tissue Infections (ESTI)Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicineA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effect of Romiplostim on Health-Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents.The Functional Arm Scale for Throwers (FAST)-Part I: The Design and Development of an Upper Extremity Region-Specific and Population-Specific Patient-Reported Outcome Scale for Throwing Athletes.Development of a quality-of-life questionnaire for adults with strabismus.Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials.A clinician's guide for conducting randomized trials in individual patients.Measuring quality of life in clinical trials: a taxonomy and review.Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditionsCNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studiesQuality of life in patients with Graves ophthalmopathy.Effectiveness of a geriatric day hospitalDevelopment and Validation of the First Iranian Questionnaire to Assess Quality of Life in Patients With Heart Failure: IHF-QoLNational Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10Questionnaire design.The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosisHow a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measureDevelopment of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL.Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver diseaseIndependent validation of the Sleep Apnoea Quality of Life IndexThe responsiveness of the Shoulder Disability QuestionnaireComparison of the responsiveness of the Harris Hip Score with generic measures for hip function in osteoarthritis of the hip.Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy.Questionnaire to measure perceived symptoms and disability in asthma.Validation of the VEINES-QOL quality of life instrument in venous leg ulcers: repeatability and validity study embedded in a randomised clinical trialA daily diary for quality of life measurement in advanced breast cancer trialsDevelopment of the Canadian Physiotherapy Assessment of Clinical Performance: A New Tool to Assess Physiotherapy Students' Performance in Clinical EducationQuality-of-life assessment after palliative interventions to manage malignant ureteral obstruction.Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL.Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trialThe effects of strabismus on quality of life in adultsCardiovascular disease. Physician attitudes toward prevention and treatment.Prospective controlled evaluation of the effect of a community based asthma education centre in a multiracial working class neighbourhoodDo generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
P2860
Q24563083-DCF65FDF-D926-4659-96C0-D1E759E82614Q24672402-C0660C48-E068-4E7E-BB93-F2DE70484586Q24794164-B3623D6F-CC59-487C-B5C2-019CAFD5AE42Q25257738-55B42D4D-5FD3-44AB-8F00-1414DAA7AAAFQ33260093-F1CA7975-6022-4DF9-99E1-602BCB581F37Q33423248-CFACD266-6766-41AB-8092-23507D961D97Q33431165-9FAB70BB-C754-42D7-A224-02F9A29DD259Q33590042-254973F2-3745-4FE8-866E-E4DFCA901889Q33635616-7899869C-2047-49DC-829A-066E9FE1462BQ33884087-63A263AB-89E0-4F7A-A050-2A3EBCADED69Q34102092-8D1E3935-6706-405D-BC52-292A79A483E9Q34104608-09E270D4-095E-424C-8F18-132A4228D2A3Q34326913-2FFB5425-A62C-4CDC-9323-030710EF4547Q34397971-6A8A17BC-E481-4F80-BCA3-475364B660E0Q34565430-4EAC7A98-386B-49EA-8B4D-159E319F36EDQ34580167-6894B854-4804-4B6E-B940-33048822B2BCQ34621693-3813193F-4B83-4B0A-BB11-2F8998FBC2AEQ34655531-68FBB55D-8ED0-401A-A70E-4F4147C74F36Q34795524-70563ED4-7588-4EE8-88CF-18D42C67E619Q35017300-1A2E6EB4-D7D2-48BF-9E24-8F5BBA86B501Q35079886-CEAB5B86-1171-497C-B9C8-9EBDA7090C9AQ35096011-2BBC362A-5E9C-4E35-B1BD-F1BD499EDB05Q35305938-48D07301-573B-4A0E-8688-5CF130FFF731Q35337675-D628819C-5658-425F-9930-99EDCC79A84DQ35356375-1E5D2624-B774-445B-B91B-37394A6003F8Q35535223-4A07A329-D2C0-4F2F-9656-075A73901A40Q35547706-18BEFB72-ECD8-4610-9C20-92FC869486C9Q35552051-EC3FE934-E18B-4DB1-B64E-B16003F39024Q35566812-5702EF6E-439F-4E00-B998-815B227B4215Q35625344-4B059EC1-4F49-4B23-ACA2-DB3872FD83D5Q35742097-BCD9890C-047A-49B8-9173-99C06DEB41F0Q35975714-28D626FD-90CA-46AC-AF51-A8622BC4FA2FQ36125792-F5E7F607-CF96-4546-95FF-7A4C90DF4E4DQ36148307-E9743025-0A58-401E-BF1B-C783565D467AQ36208526-AD23EE72-B079-44E1-8015-F5180CF03689Q36433196-828C8F22-3590-4AD4-A1D8-72BD192E7983Q36456800-F9174235-3BD5-46EB-8200-BC9D6CBB679CQ36515216-C3E3CBF6-CB6F-4B32-AFE7-A7644BE613D1Q36576321-BC1E6F74-E35B-4AD6-B1BE-C3CBEAA44CDAQ36831616-F6676ED7-694C-475E-B5D9-B11CC7DD4BBC
P2860
Measuring disease-specific quality of life in clinical trials.
description
1986 nî lūn-bûn
@nan
1986 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Measuring disease-specific quality of life in clinical trials.
@ast
Measuring disease-specific quality of life in clinical trials.
@en
Measuring disease-specific quality of life in clinical trials.
@nl
type
label
Measuring disease-specific quality of life in clinical trials.
@ast
Measuring disease-specific quality of life in clinical trials.
@en
Measuring disease-specific quality of life in clinical trials.
@nl
prefLabel
Measuring disease-specific quality of life in clinical trials.
@ast
Measuring disease-specific quality of life in clinical trials.
@en
Measuring disease-specific quality of life in clinical trials.
@nl
P2093
P2860
P1476
Measuring disease-specific quality of life in clinical trials.
@en
P2093
Bombardier C
Tugwell PX
P2860
P304
P407
P577
1986-04-01T00:00:00Z